Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: The EVEREST outcome trial

Article Abstract:

A study was conducted to investigate the effects of tolvaptan initiated in patients hospitalized with heart failure (HF). The Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) trial indicated that tolvaptan initiated for acute treatment of patients hospitalized with HF had no effect on long-term mortality or heart failure-related morbidity.

Author: Burnett, John C., Jr., Gheorghiade, Mihai, Zannad, Faiez, Maggioni, Aldo P., Swedberg, Karl, Konstam, Marvin A., Orlandi, Cesare, Grinfeld, Liliana, Udelson, James E., Cook, Thomas, Ouyang, John, Zimmer, Christopher
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2007
Heart failure, Vasopressin, Vasopressins

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure

Article Abstract:

A program is carried out with heart patients to study the effect of the angiotensin receptor blocker candesartan on myocardial infarction (MI) and other coronary disorders. Findings prove that the danger of the combined outcome of cardiovascular death or nonfatal MI markedly decreases with candesartan.

Author: Yusuf, Salim, Granger, Christopher B., Pfeffer, Marc A., Michelson, Eric L., McMurray, John J.V., Swedberg, Karl, Demers, Catherine, Olofsson, Bertil, McKelvie, Robert S., Ostergren, Jan, Johansson, Peter A., Duolao Wang
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
Complications and side effects, Medical examination, Cardiac patients, Candesartan

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction

Article Abstract:

The advantages of using the glucose-insulin-potassium (GIK) therapy for patients with ST-segment elevation myocardial infarction (STEMI) are studied. GIK infusion is found to be of no significant benefit to such patients.

Author: Yusuf, Salim, Jun Zhu, Avezum, Alvaro, Mehta, Shamir R., Ruda, Mikhail, Kazmi, Khawar, Diaz, Rafael, Goyal, Abhinav, Afzal, Rizwan, Xavier, Denis, Pais, Prem, Chrolavicius, Susan, Lisheng Liu, Budaj, Andrej, Zubaid, Mohammad
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2007
Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Potassium Supplements, Health aspects, Care and treatment, Drug therapy, Combination, Combination drug therapy, Insulin, Glucose, Dextrose, Potassium in the body, Potassium (Nutrient)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Drug therapy, Dosage and administration, Clinical report, Heart attack
Similar abstracts:
  • Abstracts: Effects of tolvaptan a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial
  • Abstracts: Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: The Oasis-6 randomized trial
  • Abstracts: Beta-Blocker Therapy for Heart Failure: The Evidence Is In, Now the Work Begins. Impact of the pulmonary artery catheter in critically ill patients: Meta-analysis of randomized clinical trials
  • Abstracts: Lactate dehydrogenase isoform activity mapping in patients with intra-amniotic infection. Pregnancy and estradiol modulate myometrial G-protein pathways in the guinea pig
  • Abstracts: Ultrasound evaluation of abnormal umbilical cord coiling in second trimester of gestation in association with adverse pregnancy outcome
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.